Exhitibitors at CPHI Japan
Our company member Alex Gruman and Patriapharma-Japan office manager Shigeru Oshikiri are present as exihibitors on the CPHI Japan from April 19-21
Hungary-Japan Economic Club
Our company became a member of the Hungary-Japan Economic Club (Magyar-Japán Gazdasági Klub)
Arab Health Expo
Our Business Development director, Alex Gruman represented our company in Dubai on the Arab Health Expo.
15 supported employer’s informative obligation
Name of beneficiary: Pátriapharma Gyógyszergyártó Kft.Amount of grant: 1.591.200 HUF Presentation of the training: Haladok a korral– IT knowledges: word and excel (24 hours), with 2 groups, in 24 hours with 15 participantsPurpose...
Development of manufacturing technology for three pharmaceutical ingredients
For three active pharmaceutical ingredients (Atracurium Besylate, Biperiden HCl, Cisatracurium Besylate) we plan to develop a manufacturing technology first on laboratory scale followed by pilot plant and finally on production scale. The quality of the pharmaceutical...
Hungarian Business Leaders Forum
Company CEO, Zita Schneider became a proud member of the Hungarian Business Leaders Forum (HBLF), and she attended their event as a member of Patriapharma Ltd.
R&D director
Imre Kovács now became the R&D director of our company. He will be leading the R&D-team, where he will oversee new synthesis, new technologies and CDMO production. CF Pharma now possesses 3 laboratories.
Site Accreditation Certificate
CF Pharma has successfully renewed the Site Accreditation Certificate, with this document out company is allowed to sell APIs to Japan territories.
Japanese GMP
The Japanese GMP Compliance Inspection Result Notification is successfully received.
Establishment of Patriapharma Japan
We are proud to announce that our commercial partner Patriapharma established its Japanese subsidiary. Patriapharma Japan Co., Ltd. which was founded on 28/12/2020 and was created with the express purpose of meeting the strict Japanese regulations and providing...
Electronic waste recycling method
We pays special attention to waste management, whether hazardous waste from production or other waste indirectly related to production. Accordingly, an integral part of our waste management is the selective collection of electronic waste and its transfer to a...
We had an AWESOME VACATION this year!
Our company organized summer camps for our employees and their children to alleviate the quarantine situation during the pandemic, which aims to replace the closed daycare during the summer period. We wanted to make our employees’ everyday lives easier and provide...
CF Pharma received HALAL certification
In April 2019 CF was successfully re-audited by IIDC Austria and received a HALAL certification for four of our active pharmaceutical ingredients: Atracurium besylate Biperiden hydrochloride Cisatracurium besylate Cabergoline
